Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RNAC compared with SMTI: revenue, margins and what each company keeps, and the suppliers and customers both name
RNAC
Cartesian Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SMTI
Sanara MedTech Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RNAC
Cartesian Therapeutics, Inc.
vs
SMTI
Sanara MedTech Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
RNAC
Cartesian Therapeutics, Inc.
Change
7.15
▲
+5.47%
Mkt cap
$208.0M
Revenue
$78,000
Q1 FY26
Revenue
$3M
FY25
SMTI
Sanara MedTech Inc.
Change
31.72
▲
+0.34%
Regular session
Nov 6 '26
Mkt cap
$290.4M
Revenue
$28M
Q2 FY26
Revenue
$103M
FY25
vs
Compare
Regular session
Nov 6 '26
RNAC
Cartesian Therapeutics, Inc.
vs
SMTI
Sanara MedTech Inc.
7.15
▲
+5.47%
Price
31.72
▲
+0.34%
$208.0M
Mkt cap
$290.4M
Q1 FY26
$78,000
Revenue
$28M
Q2 FY26
FY25
$3M
Revenue
$103M
FY25
Change
Change
RNAC
7.15
▲
+5.47%
vs
SMTI
31.72
▲
+0.34%
Regular session
Nov 6 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RNAC
8
BIIB
Biogen MA, Inc., or Biogen
supplier
—
National Institutes of Health
unlisted
supplier
—
Genovis AB (publ.)
unlisted
supplier
—
NCI
unlisted
supplier
4 more · RNAC chain
›
Shared
0
No disclosed counterparties: SMTI.
Only SMTI
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR